EFFECT OF TAMOXIFEN ON POSTMENOPAUSAL ENDOMETRIUM IN BREAST CANCER PATIENTS

被引：0
|
作者：
Mamic, I. [1 ]
Danolic, D. [1 ]
Kostic, L. [1 ]
Alvir, I. [1 ]
Tomica, D. [2 ]
Banovic, M. [3 ]
Puljiz, M. [1 ]
机构：
[1] Univ Hosp Ctr Sestre Milosrdnice, Univ Hosp Tumors Dept Gynecol Oncol, Zagreb, Croatia
[2] Reg Hosp Hartberg, Dept Gynecol & Obstet, Hartberg, Austria
[3] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0068
引用
收藏
页码：1044 / 1044
页数：1
相关论文
共 50 条
  • [31] Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant
    Leilani Morales
    Patrick Neven
    Dirk Timmerman
    Hans Wildiers
    Maja L. Konstantinovic
    Marie-Rose Christiaens
    Peter N. Tan
    Robert Paridaens
    Breast Cancer Research and Treatment, 2009, 117
  • [32] Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Hutson, PR
    Love, RR
    Havighurst, TC
    Rogers, E
    Cleary, AF
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8722 - 8727
  • [33] Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
    Kjoe, Philippe R. Lee Meeuw
    Kieffer, Jacobien M.
    Small, Brent J.
    Boogerd, Willem
    Schilder, Christina M.
    van der Wall, Elsken
    Kranenbarg, Elma Meershoek-Klein
    van de Velde, Cornelis J. H.
    Schagen, Sanne B.
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [34] Serum homocysteine levels in postmenopausal breast cancer patients treated with tamoxifen
    Love, RR
    Anker, G
    Yang, YH
    Refsum, H
    Ueland, PM
    Lonning, PE
    Lien, EA
    CANCER LETTERS, 1999, 145 (1-2) : 73 - 77
  • [35] High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen
    Cohen, I
    Beyth, Y
    Shapira, J
    Tepper, R
    Fishman, A
    Cordoba, M
    Bernheim, J
    Yigael, D
    Altaras, MM
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1997, 44 (03) : 200 - 205
  • [36] Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
    Wegman, P
    Vainikka, L
    Stål, O
    Nordenskjöld, B
    Skoog, L
    Rutqvist, LE
    Wingren, S
    BREAST CANCER RESEARCH, 2005, 7 (03): : R284 - R290
  • [37] Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
    Pia Wegman
    Linda Vainikka
    Olle Stål
    Bo Nordenskjöld
    Lambert Skoog
    Lars-Erik Rutqvist
    Sten Wingren
    Breast Cancer Research, 7
  • [38] ADJUVANT TAMOXIFEN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH OPERABLE BREAST-CANCER
    WALLGREN, A
    BARAL, E
    GLAS, U
    KARNSTROM, L
    NORDENSKIOLD, B
    THEVE, NO
    SILFVERSWARD, C
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 23 (6B): : 1161 - 1162
  • [39] Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen
    Özsener, S
    Özsaran, A
    Itil, I
    Dikmen, Y
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (06) : 580 - 583
  • [40] ENDOMETRIAL CHANGES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS RECEIVING TAMOXIFEN
    LAHTI, E
    BLANCO, G
    KAUPPILA, A
    APAJASARKKINEN, M
    TASKINEN, PJ
    LAATIKAINEN, T
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (05): : 660 - 664
12345